Cynata Therapeutics adds new sitefor MEND clinical trialMay 30, 2022LATEST NEWS Australian cell therapy company Cynata Therapeutics (ASX:CYP) has announced that St George Hospital in Sydney is now a participatingsite and is seeking to recruit patients in the MEND clinical trial. The pilot, open-label, randomised controlled clinical trial is investigating the earlyefficacy of CYP-001 in adults admitted to intensive care with respiratory failure.Cynata's chief medical officer Dr Jolanta Airey said,& "We are very pleased St GeorgeHospital is non the MEND trial We nassed the halfwavhe trial
Cynata Therapeutics adds new sitefor MEND clinical trialMay 30,...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 17.0¢ | 15.5¢ | $47.10K | 289.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 23813 | 3 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |